Abstract
The present study is designed to investigate the effect of pre-conditioning with 35% O2 on PC12 cell death induced by hypoxia. This study investigated whether 35% O2 pre-conditioning for 3 h, followed by 12 h recovery, can protect PC12 cells against death induced by subsequent exposure to hypoxia for 72 h. The result showed that pre-conditioning with 35% O2 partly blocked the decrease in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction induced by hypoxia in PC12 cells. PC12 cells pre-conditioned with 35% O2 could generate a small quantity of reactive oxygen species (ROS), which activated the extracellular signal-regulated kinase (ERK) signalling pathway, then the over-expression of the B-cell lymphoma/leukaemia-2 (Bcl-2) was induced, which subsequently protected PC12 cell against death resulting from hypoxia exposure. In conclusion, 35% O2 pre-conditioning could protect PC12 cells against hypoxic insult.
Abbreviations | ||
DMEM | = | Dulbecco's modified Eagle's medium |
SiRNA | = | small interfering RNA |
PYR | = | pyrogallol |
CAT | = | catalase |
H2O2 | = | hydrogen peroxide |
TEM | = | 4-hydroxyl-tempol |
PD | = | PD98059 |
DCFH-DA | = | dichlorofluorescein diacetate |
Het | = | dihydroethidium |
H7 | = | 1-5-isoquinolinesulphonyl-2-methypoperazine |
DMSO | = | dimethyl sulphoxide |
WO | = | wortmannin |
MTT | = | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylterazolium bromide |
DCF | = | dichlorofluorescein |
ROS | = | reactive oxygen species |
IPC | = | ischemic pre-conditioning |
PC12 | = | pheochromocytoma |
PMSF | = | phenylmethylsulphonylfluoride |
ERK | = | extracellular signal-regulated kinase |
MAPK | = | mitogen-activated protein kinase |
PKC | = | protein kinase C |
PKA | = | protein kinase A |
PI3K | = | phosphoinositide-3-kinase |
EGTA | = | ethylene glycol tetraacetic acid |
CREB | = | cyclic AMP-responsive element binding protein |
Bcl-2 | = | B-cell lymphoma/leukaemia-2 |
NF-B | = | nuclear factor B |
DEPC | = | diethyl-pyrocarbonate |
AMV-RT | = | avian myeloblastosis virus reverse transcriptase. |
Abbreviations | ||
DMEM | = | Dulbecco's modified Eagle's medium |
SiRNA | = | small interfering RNA |
PYR | = | pyrogallol |
CAT | = | catalase |
H2O2 | = | hydrogen peroxide |
TEM | = | 4-hydroxyl-tempol |
PD | = | PD98059 |
DCFH-DA | = | dichlorofluorescein diacetate |
Het | = | dihydroethidium |
H7 | = | 1-5-isoquinolinesulphonyl-2-methypoperazine |
DMSO | = | dimethyl sulphoxide |
WO | = | wortmannin |
MTT | = | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylterazolium bromide |
DCF | = | dichlorofluorescein |
ROS | = | reactive oxygen species |
IPC | = | ischemic pre-conditioning |
PC12 | = | pheochromocytoma |
PMSF | = | phenylmethylsulphonylfluoride |
ERK | = | extracellular signal-regulated kinase |
MAPK | = | mitogen-activated protein kinase |
PKC | = | protein kinase C |
PKA | = | protein kinase A |
PI3K | = | phosphoinositide-3-kinase |
EGTA | = | ethylene glycol tetraacetic acid |
CREB | = | cyclic AMP-responsive element binding protein |
Bcl-2 | = | B-cell lymphoma/leukaemia-2 |
NF-B | = | nuclear factor B |
DEPC | = | diethyl-pyrocarbonate |
AMV-RT | = | avian myeloblastosis virus reverse transcriptase. |